• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Immune Thrombocytopenia

Immune Thrombocytopenia - 36 Studies Found

Not yet recruiting : A Single-center Clinical Trial of Bortezomib in Management of Immune Thrombocytopenia (ITP)
: Immune Thrombocytopenia
: 2016-12-22
: Drug: Bortezomib Bortezomib was given by intravenous bolus injection at a dose of 1.3 mg/m2 on days 1, 4
Completed : A Multi-center Study of Low-dose Decitabine for the Treatment of Immune Thrombocytopenia
: Immune Thrombocytopenia
: 2012-03-29
: Drug: Decitabine Decitabine 3.5mg/m2,ivdrip,qd x 3d, every four weeks for one cycle. It wi
Completed : Clinical Trial of Gut Microbiota in the Management of Immune Thrombocytopenia
: Immune Thrombocytopenia
: 2017-01-16
:
  • Drug: Probiotic Agent probioti

Withdrawn : The Alteration of Macrophage Function in the Spleen Tissues From Patients With Primary Immune Thrombocytopenia
: Immune Thrombocytopenia
: 2013-04-03
Completed : Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia
: Immune Thrombocytopenia
: 2014-11-17
:
  • Drug: Eltrombopag Investigatio

Completed : End of EXTEND: Discontinuation of Medication for Patients With Immune Thrombocytopenia
: Immune Thrombocytopenia
: 2011-06-13
: Drug: Discontinuation of eltrombopag Observation of subjects as they discontinue the use of eltrombopag
Withdrawn : A Multicenter Investigation of Recombinant Human Thrombopoietin (rhTPO) Combining Cyclosporin A Versus Cyclosporin A in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia (ITP)
: Immune Thrombocytopenia
: 2014-07-27
:
  • Drug: Cyclosporin A given oral

Completed : An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP)
: Immune Thrombocytopenia
: 2014-05-29
:
  • Drug: Dexamethasone Dexamethas

Active, not recruiting : Polymorphism and Auto-reactive B and T Cells Subsets in Adult's Immune Thrombocytopenia (ITP)
: Immune Thrombocytopenia
: 2014-11-06
: Other: blood sample
Completed : An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia
: Immune Thrombocytopenia
: 2014-02-13
: Drug: Human immunoglobulin intravenous After GC5107A Intravenous injection, evaluate platelet increase
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.